Sign In
Buy FLDM
$1.83
+0 (+0%)
At Close: Jul 20, 2022
Groundbreaking Development in Rapid Large-Scale COVID-19 Testing
11:47am, Saturday, 25'th Apr 2020
University of Oklahoma Medicine, University of Oklahoma Health Sciences Center and Oklahoma Medical Research Foundation file for FDA Emergency Use Authorization for COVID-19 detection test utilizing f
Global Real Time PCR (qPCR) market is valued at US$ 4,154.9 Mn in 2018 and is expected to grow at a CAGR of 8.8% to reach US$ 8,890.5 Mn in 2027. Rise in COVID-19 pandemic is increasing the demand for
OU Medicine, OU, OMRF file for EUA for test using Fluidigm technology FLDM
01:27pm, Thursday, 23'rd Apr 2020
OU Medicine, OU, OMRF file for EUA for test using Fluidigm technology FLDM
The spread of this disease has been declared a global pandemic by the World Health Organization. The test, developed by OMRF and OU Health Sciences Center scientists and utilizing Fluidigm products,
Expediting Treatment of COVID-19 Patients and Enhancing Testing Resources for Caregivers in Oklahoma Workflow from Extraction through Real-Time PCR...
Assenagon Asset Management S.A. Buys Shares of 475,465 Fluidigm Co. (NASDAQ:FLDM)
08:48am, Thursday, 23'rd Apr 2020
Assenagon Asset Management S.A. acquired a new position in shares of Fluidigm Co. (NASDAQ:FLDM) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission
BRIEF-Fluidigm Corp - On April 21, Co And Silicon Valley Bank Entered Into Third Amendment To Loan And Security Agreement
09:35pm, Wednesday, 22'nd Apr 2020
Fluidigm Corp:
Fluidigm Co. (NASDAQ:FLDM) Shares Sold by Bank of New York Mellon Corp
08:48am, Wednesday, 22'nd Apr 2020
Bank of New York Mellon Corp cut its holdings in shares of Fluidigm Co. (NASDAQ:FLDM) by 2.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission.
Fluidigm Announces Conference Call and Webcast of First Quarter 2020 Financial Results
08:06pm, Monday, 20'th Apr 2020
SOUTH SAN FRANCISCO, Calif., April 20, 2020 -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through.
Goldman Sachs Group Inc. Sells 203,081 Shares of Fluidigm Co. (NASDAQ:FLDM)
11:16am, Monday, 20'th Apr 2020
Goldman Sachs Group Inc. decreased its holdings in Fluidigm Co. (NASDAQ:FLDM) by 47.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Comm
Cubist Systematic Strategies LLC Sells 76,296 Shares of Fluidigm Co. (NASDAQ:FLDM)
10:02am, Monday, 20'th Apr 2020
Cubist Systematic Strategies LLC lowered its position in shares of Fluidigm Co. (NASDAQ:FLDM) by 81.6% during the 4th quarter, according to the company in its most recent filing with the Securities &
Highlight Therapeutics appoints Dr. Carlos Paya as Executive ChairmanandSignificantly expands Scientific Advisory Board
08:01am, Friday, 17'th Apr 2020
Dr Ralph Weichselbaum, Dr. Antoni Ribas & Michael Docherty appointed to SAB Company renamed to Highlight Therapeutics MADRID, Spain, April 17, 2020 -- Highlight.
Genomics Industry Review 2015-2019 and Opportunity Outlook 2020-2030
11:00pm, Thursday, 16'th Apr 2020
The "Genomics Market Global Report 2020-30" report has been added to ResearchAndMarkets.com's offering.
Global Genomics Market Outlook Report, 2020-2030 - Market Set to Reach $1.47 Billion by 2023 - ResearchAndMarkets.com
03:08pm, Thursday, 16'th Apr 2020
The "Genomics Market Global Report 2020-30" report has been added to ResearchAndMarkets.com's offering.
Fluidigm Provides Update on COVID-19 Impact and Preliminary Revenue Estimate for First Quarter 2020
08:05pm, Tuesday, 14'th Apr 2020
Fluidigm has been actively responding to the pandemic by protecting our employees and serving urgent customer needs while managing our liquidity. As Fluidigm is a designated essential business, our e
